stella
beta
A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11) — Stella
Recruiting
Back to Immune Thrombocytopenia (ITP) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Qilu Hospital of Shandong University, Jinan, Shandong
View full record on ClinicalTrials.gov